Log In
Print
BCIQ
Print
Print this Print this
 

andexanet alfa (PRT064445, PRT4445)

  Manage Alerts
Collapse Summary General Information
Company Portola Pharmaceuticals Inc.
DescriptionRecombinant protein that reverses the anticoagulant activity of Factor Xa inhibitors
Molecular Target
Mechanism of ActionReverse anticoagulant
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today